Biocom CFO Presents: Investor Relations – A Critical CFO and Board Priority

Research shows that an effective investor relations program can account for a 30% variance in a company’s valuation. Investor communications is a vital function at any publicly traded company, and an active agenda topic at board meetings. We’ve assembled CFO’s and board members to share their perspective on key investor relations topics that matter to boards and to provide recommendations for CFOs and investor relations officers engaging with the board of directors. Moderated by a former investor relations officer turned CFO, we will discuss the interplay between the board, the CFO and the IRO on financing, forecasting, governance, and shareholder communications.